You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪眼科(03309.HK)預計上半年淨利1000萬港元-1500萬港元 扭虧為盈
格隆匯 08-05 19:16

格隆匯8月5日丨 希瑪眼科(03309.HK)公吿,根據目前可得的資料及對集團截至2021年6月30日止6個月("2021年上半年")未經審核綜合管理賬目的初步審閲,董事預計集團於2021年上半年錄得的淨利潤將介於1000萬港元至1500萬港元,而集團於截至2020年6月30日止6個月則錄得淨虧損2220萬港元。

集團實現轉虧為盈,主要由於集團收益較截至2020年6月30日止6個月的2.62億港元大幅增加逾90%,惟收益增長對集團盈利的影響被集團處於投資階段的醫院造成的淨虧損所部分抵銷。

該等醫院包括位於惠州的新醫院(最近於2021年3月31日開始營業),以及位於珠海的眼科醫院(由集團於2020年8月收購,並於2020年12月22日開始營業)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account